Skip to main content
US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
MT

MTLSStockMaterialise Nv - ADR

Nasdaq Global Select Market · Technology

$6.21 last close 2026-11-16
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment MTLS's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Per our secondary compliance provider · assessed 2026-05-12 4 mo old
Purification 100.00%HTR non-permissible income <0.01%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure1 of 5 timeframes bullish · 95.7% aligned
VWAPPrice below VWAP ($6.61)
VolumeRelative volume 2.8× the 20-day average
Momentum10-day rate of change -14.0%

Materialise Nv - ADR (MTLS) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-05-12). See the full ratio breakdown and business-activity screen below for the reasoning. ⚠️ This provider verdict is about 4 months old (2026-05-12) — older than one reporting quarter, so it may predate the financial data shown below.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

432 other Technology stocks pass this same screen. See compliant Technology stocks →

Market & analysts
Price target
$9.82
+58.1% · 3 analysts
Institutional own.
14.5%
of shares
Momentum (10d)
-14.0%
rate of change
SMC grade
F · 32
95.7% aligned
<0.01%
Non-permissible income — HTR, from filings (2024-12-31)
F · 32
SMC grade — 95.7% timeframe alignment
-14.0%
Rate of change (10d)
$9.82
Price target (+58.1%) · 3 analysts
14.5%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for MTLS — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding MTLS
InvestorFirmPositionWeightAs of
Cathie Wood ARK Investment Management $3M 0.0% 2026-09-30
Peter Brown Renaissance Technologies $2M 0.0% 2026-09-30
Ken Griffin Citadel Advisors $2M 0.0% 2026-09-30
Steven Cohen Point72 Asset Management $0M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

8.757.766.785.794.802025-11-172026-05-192026-11-16

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
6.23
S2
6.34
S1
6.42
PIVOT
6.53
R1
6.61
R2
6.72
R3
6.80

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
7.81 – 9.13
±7.74% from 8.47, made 2026-09-28 · resolves 2026-10-05
STRONG BUY
from 19 indicators
74.9% of our last 10571 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.2% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsBUY
4 buy · 0 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)29.60BUY
Stochastic %K (14)1.28BUY
CCI (20)-111.39BUY
Williams %R (14)-98.72BUY
MACD (12,26,9)-0.10SELL
ROC (10)-13.99SELL
Momentum (10)-1.01SELL
EMA (10)6.80SELL
SMA (10)6.79SELL
EMA (20)7.17SELL
SMA (20)7.37SELL
EMA (30)7.36SELL
SMA (30)7.67SELL
EMA (50)7.45SELL
SMA (50)7.80SELL
EMA (100)7.25SELL
SMA (100)7.30SELL
EMA (200)6.66SELL
SMA (200)6.45SELL

About Materialise Nv - ADR

Technology · Software - Application

Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.

materialise.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

No real edge — avoid

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 42
⏰ 4H BEARISH 26
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-14.0%
Rate of change (10d)
2.8×
Volume vs its 20-day average
-0.44
MACD (no fresh cross)
$6.22
Volume POC (today)
$6.20 – $6.29
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.